Humedics Targets Chinese Market... Launches Joint Brand 'Derma Revi'

Collaboration with Shangli Biotech

Huons Group's aesthetic subsidiary, Humedix, is launching an attack on the Chinese cosmetics market.

Humedics Derma Levi logo. [Photo by Humedics]

Humedix announced on the 14th that it has launched the joint venture brand "Derma Revie" with Xiangli Biotech in China.

Derma Revie is a brand created to enter the Chinese market, featuring Humedix's technology and high-functional ingredients. Recently, two moisturizing products, "Soothing Repairing Cream" and "Soothing Repairing Lotion," were registered with the National Medical Products Administration (NMPA) of China and are scheduled to be launched nationwide in China starting in July.

The Soothing Repairing Cream and Lotion contain highly purified beta-glucan extracted from Chaga mushroom, combined with a patented Derma Soothing Complex to help strengthen the skin barrier and provide moisture. They also include four complex Centella Asiatica ingredients such as madecassoside and madecassic acid, along with active ingredients like panthenol and allantoin to help protect the skin.

Starting with the Soothing Repairing products, Humedix plans to expand the Derma Revie lineup to strengthen its influence in the Chinese market. Humedix recently completed NMPA registration for its own brand "Elravie Revitalex Ampoule." The Elravie Revitalex Ampoule is a high-functional product mainly composed of polynucleotide (PDRN) and hyaluronic acid. Distribution will continue mainly through hospitals and clinics, with plans to expand the premium ampoule line, including the Elravie Glowrex Ampoule, in the future.

Jinhwan Kim, CEO of Humedix, stated, "We will continue to launch differentiated high-functional products and expand our lineup to meet the diverse needs of Chinese consumers."

This content was produced with the assistance of AI translation services.